Encap wins commercial manufacturing contract
For a large volume, licensed drug
Encap Drug Delivery, a contract development and manufacturing organisation (CDMO) dedicated to liquid and semi-solid (hot melt) filled capsules, has added a further pharmaceutical product to its portfolio of commercial products.
Chief executive Dr Stephen Brown said the commercial manufacturing contract is for a proprietary pharmaceutical product currently licensed in Europe, which is transferring to Encap from the existing CDMO.
‘This is a large volume, licensed pharmaceutical and the award of this contract demonstrates that in addition to its excellent development services capability, Encap is able to provide a best in class commercially competitive manufacturing service,’ said Brown.
Encap is working closely with its client to prepare for the successful launch of this and other pharmaceutical products during the year.
Encap is a privately held company founded 23 years ago, which has spent the last few years building its development services capability. It has manufacturing facilities in Livingston, UK, which have been successfully audited by the European MHRA and US FDA, and employs more than 70 people dedicated to the liquid fill hard capsule technology.
Dr Brown says Encap has firmly established its credentials as a reliable development services and drug delivery partner (now accounting for 50% of the company’s revenues) and will continue the expansion of its commercial manufacturing business. This includes highly potent compounds or those requiring special handling as the company now has dedicated high containment facilities within its Livingston plant.
